Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Sierra Bancorp
BSRR
$528M
| $318K | ﹤0.01% |
11,842
+2,248
| +23% | +$56.5K |
|
|
GHL
3427
DELISTED
Greenhill & Co., Inc.
GHL
| $318K | ﹤0.01% |
19,279
-9,327
| -33% | -$138K |
|
3428
iShares S&P GSCI Commodity-Indexed Trust
GSG
$998M
| $317K | ﹤0.01% |
+22,662
| New | +$311K |
|
|
VOXX
3429
DELISTED
VOXX International Corporation Class A
VOXX
| $316K | ﹤0.01% |
16,578
+10,178
| +159% | +$212K |
|
|
DLA
3430
DELISTED
Delta Apparel Inc.
DLA
| $316K | ﹤0.01% |
11,629
-1,096
| -9% | -$26.9K |
|
3431
Clearfield
CLFD
$411M
| $315K | ﹤0.01% |
10,426
-4,992
| -32% | -$158K |
|
3432
Global X Lithium & Battery Tech ETF
LIT
$1.51B
| $315K | ﹤0.01% |
5,385
-24,658
| -82% | -$1.61M |
|
|
HTB
3433
HomeTrust Bancshares
HTB
$860M
| $315K | ﹤0.01% |
12,917
+7,870
| +156% | +$178K |
|
3434
Allient
ALNT
$1.49B
| $314K | ﹤0.01% |
9,186
+5,638
| +159% | +$186K |
|
3435
CALL
Cigna
CI
$73.7B
| $314K | ﹤0.01% |
1,300
-18,496
| -93% | -$4.12M |
|
3436
Old Second Bancorp
OSBC
$1.29B
| $314K | ﹤0.01% |
23,770
+14,592
| +159% | +$172K |
|
|
GOLD
3437
Gold.com Inc
GOLD
$1.2B
| $313K | ﹤0.01% |
17,390
+14,226
| +450% | +$223K |
|
|
UBFO
3438
DELISTED
United Security Bancshares
UBFO
| $312K | ﹤0.01% |
38,159
+14,661
| +62% | +$111K |
|
|
HMLP
3439
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $311K | ﹤0.01% |
+21,419
| New | +$331K |
|
3440
Oppenheimer Holdings
OPY
$1.14B
| $310K | ﹤0.01% |
7,757
+4,762
| +159% | +$176K |
|
3441
POSCO
PKX
$16.1B
| $310K | ﹤0.01% |
4,300
| – | – |
|
3442
Rocky Brands
RCKY
$366M
| $310K | ﹤0.01% |
5,740
+1,025
| +22% | +$40.3K |
|
|
EFL
3443
DELISTED
Eaton Vance Floating-Rate 2022 Target Term Trust Common Shares of Beneficial Interest
EFL
| $310K | ﹤0.01% |
+33,332
| New | +$308K |
|
3444
CNB Financial Corp
CCNE
$1.04B
| $309K | ﹤0.01% |
12,545
+7,767
| +163% | +$184K |
|
3445
Cartesian Therapeutics
RNAC
$229M
| $309K | ﹤0.01% |
2,274
+307
| +16% | +$38.1K |
|
3446
Colony Bankcorp
CBAN
$465M
| $306K | ﹤0.01% |
19,577
+4,721
| +32% | +$69K |
|
|
IIF
3447
Morgan Stanley India Investment Fund
IIF
$217M
| $305K | ﹤0.01% |
+11,392
| New | +$263K |
|
|
LBC
3448
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $305K | ﹤0.01% |
25,726
+11,334
| +79% | +$121K |
|
3449
ADMA Biologics
ADMA
$1.96B
| $303K | ﹤0.01% |
172,425
+172,339
| +200,394% | +$394K |
|
3450
Cue Biopharma
CUE
$113M
| $302K | ﹤0.01% |
824
+379
| +85% | +$156K |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.